J. Nucl. Med.
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of Lu-DOTATATE Peptide Receptor Radionuclide Therapy.
Related Questions
New answer by Medical Oncologist at University of Iowa Carver College of Medicine (May 7, 2020)
Unfortunately there is no safety data for the use of PRRT in patients with GFR <30 ml/min. A creatinine clearance <50 ml/min is listed only as a relative contraindicatio...